Concepedia

Author

Marie Sanda

National Cancer Institute

Also Known As

M G Sanda, M Sanda, M. G. Sanda, M. Sanda, MARTIN G. SANDA, Marie Sanda

18

Publications

2.3K

Citations

13

H-Index

14

Concepts

All Affiliations

National Cancer InstituteUCLA Medical CenterNational Institutes of HealthUniversity of Miami
MS

About

Marie Sanda is an author at National Cancer Institute specializing in medicine, pharmacotherapy, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.9K

2

Gastroenterology

2

2

99

3

Pharmacology

2

2

1.8K

4

Anesthesia

1

1

78

5

Rheumatology

1

1

1.8K

Marie Sanda

×

13

Publications

2.1K

Citations

12

H-Index

YearCitations

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Lars Klareskog, Désirée van der Heijde, J Jäger,

The Lancet

2004

1.8K

An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.

François Lanza, M F Rack, Melvyn Lynn,

PubMed

1987

78

Induction of Tumor Antigen-Specific Immunity In Vivo by a Novel Vaccinia Vector Encoding Safety-Modified Simian Virus 40 T Antigen

Yingying Xie, Clara Hwang, Willem W. Overwijk,

JNCI Journal of the National Cancer Institute

1999

35

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

Marie Sanda, Jinru Yang, S L Topalian,

Journal of Clinical Oncology

1992

32

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer

David J. Cole, Marie Sanda, James Chih‐Hsin Yang,

JNCI Journal of the National Cancer Institute

1994

32

Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis

Honghui Zhou, Mary Buckwalter, Joseph Boni,

International Journal of Clinical Pharmacology and Therapeutics

2004

31

Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis.

Harold E. Paulus, Daniel Di Primeo, Marie Sanda,

PubMed

2000

30

Gastrointestinal Blood Loss in Arthritic Patients Receiving Chronic Dosing with Etodolac and Piroxicam

Nader S. Jallad, Dyal C. Garg, Donald J. Weidler,

The American Journal of the Medical Sciences

1986

21

Etodolac kinetics in the elderly

JoAnn Scatina, David Hicks, M. Kraml,

Clinical Pharmacology & Therapeutics

1986

17

Minimum Effective Dose of Etodolac for the Treatment of Rheumatoid Arthritis

G Jacob, Marianne Messina, Jacqueline Kennedy,

The Journal of Clinical Pharmacology

1986

16

Page 1